Content and quality of clinical practice guidelines for the management of type 2 diabetes in India: A systematic review
Authors
Oluwasegun Olujide
Lifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK
Mariama Olujide
Waziri Shehu Gidado General Hospital, Kano, Nigeria
Jo Leonardi‐Bee
Lifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK
Kaushik Chattopadhyay
Lifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK
Keywords:
clinical practice guideline, India, systematic review, type 2 diabetes mellitus
Abstract
Introduction
Over the last few decades, India has witnessed an increase in the number of people with type 2 diabetes mellitus (T2DM). Consequently, several clinical practice guidelines (CPGs) have been developed to assist western and traditional Indian medicine practitioners in managing this disease. This systematic review aimed to evaluate and synthesize the content and quality of these CPGs.
Methods
Several databases and sources were searched from inception to May 2022, to identify CPGs for managing adults with T2DM in India. The screening of titles and abstracts and full texts, data extraction and quality assessment were conducted by two independent reviewers. Any disagreements were resolved through discussion or by involving a third reviewer. A data extraction tool from a previous study was adapted to extract the content of the included CPGs, and the Appraisal of Guidelines for Research and Evaluation II tool was used to assess the quality of the included CPGs. A narrative synthesis was conducted.
Results
Of 3350 records identified, 11 were retrieved for full‐text screening and five CPGs were included in this systematic review—three focused on traditional Indian medicine (Ayurveda) and two focused on western medicine. These two western medicine CPGs contained comprehensive recommendations for managing T2DM but only one of these, the Research Society for the Study of Diabetes in India/Endocrine Society of India (RSSDI/ESI) CPG, was of high quality.
Conclusions
Only one CPG can be recommended for managing T2DM by western medicine practitioners in India. Future CPGs, especially for traditional Indian medicine practitioners, should be developed and updated using the standard CPG manuals and quality appraisal tools.
Registration
PROSPERO (CRD42021279499).
Keywords: clinical practice guideline, India, systematic review, type 2 diabetes mellitus
Author Biographies
Jo Leonardi‐Bee, Lifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK
The Nottingham Centre for Evidence‐Based Healthcare: A JBI Centre of Excellence, Nottingham, UK
Kaushik Chattopadhyay, Lifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK
The Nottingham Centre for Evidence‐Based Healthcare: A JBI Centre of Excellence, Nottingham, UK
Click on "Archives" to access the full archive of scientific preprints. You may use the categories and the search functionality to find select preprints you're interested in.
